0001415889-24-029683.txt : 20241217 0001415889-24-029683.hdr.sgml : 20241217 20241217192941 ACCESSION NUMBER: 0001415889-24-029683 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241216 FILED AS OF DATE: 20241217 DATE AS OF CHANGE: 20241217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zojwalla Naseem CENTRAL INDEX KEY: 0001905871 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 241557298 MAIL ADDRESS: STREET 1: C/O OLEMA PHARMACEUTICALS, INC. STREET 2: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001750284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 300409740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 651-3316 MAIL ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 4 1 form4-12182024_121237.xml X0508 4 2024-12-16 0001750284 Olema Pharmaceuticals, Inc. OLMA 0001905871 Zojwalla Naseem C/O OLEMA PHARMACEUTICALS, INC. 780 BRANNAN ST SAN FRANCISCO CA 94103 false true false false CHIEF MEDICAL OFFICER 0 Common Stock 2024-12-16 4 M 0 14000 4.87 A 129509 D Stock Option (Right to Buy) 4.87 2024-12-16 4 M 0 14000 0 D 2033-01-31 Common Stock 14000 112840 D 25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. /s/ Shane Kovacs, Attorney-in-Fact 2024-12-17